FindTrial
Sign In

Treatment of pupillary visual quality loss in patients with acute closure by pupillary angioplasty

Treatment of pupillary visual quality loss in patients with acute closure by pupillary angioplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052566
Enrollment
Unknown
Registered
2021-10-31
Start date
2021-11-11
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

pupillary angioplasty group:Nil

Sponsors

Eye Hospital Affiliated to Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The study eye was diagnosed with pupil dilation due to iris atrophy after the acute episode of primary angle-closure glaucoma, and the pupil diameter>5mm under daily illumination (100c/d); 2. Vsc < 0.8,Vcc < 1.0; 3. Aged 18 years or above.

Exclusion criteria

Exclusion criteria: 1. Fundus lesions: such as retinal detachment, retinal hiatus, peripheral retinal degeneration, CRVO, ARVO, diabetic retinopathy, pathological myopia, ocular trauma, etc; 2. Vsc < FC/1m; 3. Have diabetes or other systemic diseases that may affect the fundus; 4. Iris related diseases: iris neovascularization, Fuchs heterochromatic iris syndrome, ICE, etc; 5. Patients with uveitis; 6. Patients with prior internal eye surgery (except for LPI and ALPI); 7. The axial length < 20mm.

Design outcomes

Primary

MeasureTime frame
surgery success rate;improve in visual acuity;—

Countries

China

Contacts

Public ContactLiang Yuanbo

Eye Hospital Affiliated to Wenzhou Medical University

yuanboliang@126.com+86 18257748686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026